Navigation Links
Novartis Phase III Study Shows ACZ885 Helped Substantially Reduce Steroid Use in 45% of Patients With Serious Form of Childhood Arthritis

 Tina Tuttle Anna Frable Novartis US Pharma Communications

Novartis US Pharma Communications+1 862 778 1625 (direct)

+1 862 778 5388 (direct)+1 862 222 6092 (mobile)

+1 732 673 5262 (mobile) 



  Novartis Investor Relations 



 Central phone:+41 61 324 7944


 Susanne Schaffert

+41 61 324 7944North America: Pierre-Michel Bringer

+41 61 324 1065

Richard Jarvis

+1 212 830 2433Thomas Hungerbuehler

+41 61 324 8425

Jill Pozarek

+1 212 830 2445Isabella Zinck

+41 61 324 7188

Edwin Valeriano

+1 212 830 2456 




e-mail: : 


SOURCE Novartis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo
2. Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe
3. Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
4. Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
5. Physicians in Europe Rate Novartis #1 on Service Delivery, While Merck Earns Top Honors in the US
6. Novartis/Schering-Ploughs Drug Will Replace AstraZenecas Symbicort as Decision Resources Clinical Gold Standard by 2012 for the Treatment of Asthma
7. Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD
8. Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure
9. Heptares Therapeutics Announces Agreement With Novartis Option Fund to Apply its StaR(TM) Technology and Generate Novel Drug Leads Against a GPCR Target
10. Novartis Class Awarded $250 Million in Punitive Damages
11. Silence Therapeutics Partner Quark Signs Exclusive Option Agreement With Novartis for Development and Commercialisation of QPI-1002
Post Your Comments:
(Date:10/8/2015)... October 8, 2015 Global ... Global Biologics and Biosimilars industry . --> ... Biologics and Biosimilars Industry 2015 Deep Market Research ... is a professional and depth research report on ... ) , --> ...
(Date:10/8/2015)... 8, 2015  Today, DuPont and Caribou Biosciences, ... editing, jointly announced a strategic alliance. As part ... respective patent portfolios, with DuPont receiving exclusive intellectual ... row crops, and non-exclusive rights in other agricultural ... --> --> In addition, the ...
(Date:10/8/2015)... 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: ... the development of autologous cell therapies, today announced its schedule ... place in the month of October: Stem ... RepliCel will be presenting at the annual Partnering Forum, ... to be held October 7-9 in La ...
(Date:10/8/2015)... ST. LOUIS , Oct. 8, 2015 /PRNewswire/ ... that the Cerilliant ® brand within its ... its new bile acid reference standards product line ... the most routinely tested bile acids and their ... materials (CRMs) consist of lithocholic acid, taurocholic acid ...
Breaking Biology Technology:
... attention focused on the effects of outsourcing technology and ... the issue. Whatever the product, there is an effort ... effects of this are hurting many aspects of Americans ... are making, whether you manufacture low- to high-tech products, ...
... a Grow Wisconsin forum in Eau Claire Thursday, Gov. ... will receive $250,000 in Technology Zone tax credits. The ... 751 jobs at its Chippewa Falls facility and invest ... complex printed computer circuit boards. The company has three ...
... Wis - The City of Muskego, Wis., has enhanced ... site and their public Web site . The ... , an Australian software company specializing in knowledge management ... , ,Prior to choosing ISYS, the City evaluated more ...
Cached Biology Technology:
(Date:9/28/2015)... , Sept. 28, 2015 Synaptics Inc. ... interface solutions, today announced that Lenovo has selected Synaptics ... sensor, FS4202, for its latest smartphone, the Vibe P1. ... access to unlock the device and provide swift access ... The feature-rich Natural ID FS4202 sensor solution utilizes ...
(Date:9/24/2015)... September 24, 2015 ... 2015 Kerv ( ... lanserar idag världens första kontaktlösa betalningsring på ... 77 000 GBP för massproduktion via crowdfunding.  ... ) , Kerv-bärare kan göra ...
(Date:9/10/2015)... 2015 Report Details The global ... upon previous expectations of revenues, consumer adoption and even ... in which wearables begin to achieve that mass market ... main reasons is the entrance of Apple to the ... market, but the overall size of the wearable technology ...
Breaking Biology News(10 mins):
... Genetics Society of America (GSA) is pleased to announce ... 2011 at the Town & Country Resort & Conference ... together basic research scientists, who study genetic models in ... hereditary traits Thomas Hunt Morgan first studied nearly a ...
... -- While scientists believe that climate change and related extreme ... the earth,s flora and fauna, just how much is not ... University and Dustin Rubenstein from Columbia University however shows an ... complex behaviors among birds. , The study, which appears in ...
... Miguel Sena-Esteves, PhD, associate professor of neurology at ... the annual "See the Light" award from the Mathew ... for leading the fight against children,s genetic diseases of ... Therapy Center at UMass Medical School, Dr. Sena-Esteves is ...
Cached Biology News:
Mouse TREM-2 Affinity Purified Polyclonal Ab...
Human BMP 2 Construction Kit provides antigen affinity purified polyclonal capture and tracer antibodies, and antigen standard for development of approximately ten microplate assays....
... pAcGHLT-A,B,C Baculovirus ... Set,pAcGHLT-XylE Baculovirus ... Powder,Thrombin Dilution ... Cocktail,Insect Cell ...
Biology Products: